Biometrics Built Better

First Time Lead Programmers: Randomised Clinical Trials vs Real World Evidence Studies

Share this article

Learn more about Randomised Clinical Trials and Real World Evidence Studies and get tips on becoming a Lead Programmer. Presented by Kirsty Parker-Hodds and Anisa Jeetoo.If you liked this webinar, you can download a copy of the slides by entering your details below.JTNDaWZyYW1lJTIwc3JjJTNEJTIyaHR0cHMlM0ElMkYlMkZnby52ZXJhbWVkLmNvLnVrJTJGbCUyRjg2MDU1MyUyRjIwMjAtMTAtMDclMkZ5Zmh4JTIyJTIwd2lkdGglM0QlMjIxMDAlMjUlMjIlMjBoZWlnaHQlM0QlMjI1MDAlMjIlMjB0eXBlJTNEJTIydGV4dCUyRmh0bWwlMjIlMjBmcmFtZWJvcmRlciUzRCUyMjAlMjIlMjBhbGxvd1RyYW5zcGFyZW5jeSUzRCUyMnRydWUlMjIlMjBzdHlsZSUzRCUyMmJvcmRlciUzQSUyMDAlMjIlM0UlM0MlMkZpZnJhbWUlM0U=

contact us

Share this article

Stay Connected

Sign up to receive the latest insights, case studies, and Veramed news—straight to your inbox.

Join our mailing list today

Related Posts

View all resources
  • Blog

Driving Outcomes Through Strategic Oversight: Best Practices in Clinical Data Management

Effective data management oversight must address both technical and compliance aspects. In this blog, we explore strategic approaches
  • Blog

Culture as a competitive edge: Veramed’s signature people-first approach 

Veramed was reaccredited as a 3-star Best Companies workplace in November 2025. In an industry where consistency, collaboration,
  • Blog

The Veramed Signature: Setting the new standard in biometrics 

With a fresh new Veramed brand, our CEO, Troy McCall, discusses the company's mission and our ongoing commitment
  • Case study

Detective Work in Data: A Case Study in CDISC Conversion Excellence

With outdated and incomplete datasets, Veramed helped a biotech client convert its legacy clinical trial data to CDISC-compliants
  • Case study

Delivering Cost-Efficient, Scalable FSP Solutions for a Top 10 Global Pharma

Building on a strong partnership of over a decade, Veramed's adaptable FSP solutions enabled a global Pharma client
  • Blog

The Evolution of the Data Manager Role in Clinical Trials: Part 2 – Inter-Trial Relationships, Growing Complexity and Anticipating the Future